Malnutrition Prevalence according to the GLIM Criteria in Head and Neck Cancer Patients Undergoing Cancer Treatment.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
13 Nov 2020
Historique:
received: 09 10 2020
revised: 04 11 2020
accepted: 11 11 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 20 4 2021
Statut: epublish

Résumé

Malnutrition is highly prevalent in people with head and neck cancer (HCN) and is associated with poorer outcomes. However, variation in malnutrition diagnostic criteria has made translation of the most effective interventions into practice challenging. This study aimed to determine the prevalence of malnutrition in a HNC population according to the Global Leadership Initiative on Malnutrition (GLIM) criteria and assess inter-rater reliability and predictive validity. A secondary analysis of data available for 188 patients with HNC extracted from two cancer malnutrition point prevalence studies was conducted. A GLIM diagnosis of malnutrition was assigned when one phenotypic and one etiologic criterion were present. Phenotypic criteria were ≥5% unintentional loss of body weight, body mass index (BMI), and subjective evidence of muscle loss. Etiologic criteria were reduced food intake, and presence of metastatic disease as a proxy for inflammation. The prevalence of malnutrition was 22.6% (8.0% moderately malnourished; 13.3% severely malnourished). Inter-rater reliability was classified as excellent for the GLIM criteria overall, as well as for each individual criterion. A GLIM diagnosis of malnutrition was found to be significantly associated with BMI but was not predictive of 30 day hospital readmission. Further large, prospective cohort studies are required in this patient population to further validate the GLIM criteria.

Identifiants

pubmed: 33203000
pii: nu12113493
doi: 10.3390/nu12113493
pmc: PMC7697929
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JPEN J Parenter Enteral Nutr. 2014 Feb;38(2):196-204
pubmed: 24748626
Clin Nutr. 2020 Sep;39(9):2872-2880
pubmed: 32563597
Clin Nutr ESPEN. 2020 Jun;37:100-106
pubmed: 32359730
Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Jun;136(3S):S27-S33
pubmed: 30846293
Clin Nutr. 2019 Feb;38(1):1-9
pubmed: 30181091
Am J Clin Nutr. 2014 Apr;99(4):875-90
pubmed: 24452240
Eur J Clin Nutr. 2002 Aug;56(8):779-85
pubmed: 12122555
Support Care Cancer. 2019 Jan;27(1):239-247
pubmed: 29938330
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
JAMA. 1988 Jul 22-29;260(4):514-8
pubmed: 3133497
J Oral Maxillofac Surg. 2013 Nov;71(11):1853-60
pubmed: 23845698
Clin Nutr. 2019 Apr;38(2):644-651
pubmed: 29789167
J Acad Nutr Diet. 2018 Apr;118(4):627-636
pubmed: 27986517
Australas Radiol. 1999 Aug;43(3):325-7
pubmed: 10901927
Am J Clin Nutr. 1981 Aug;34(8):1593-9
pubmed: 7270483
Epidemiology. 1995 Jan;6(1):61-6
pubmed: 7888448
Head Neck. 1998 Sep;20(6):540-8
pubmed: 9702542
Radiother Oncol. 2008 May;87(2):195-200
pubmed: 18342966
Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):249-58
pubmed: 26109912
Clin Nutr. 2005 Oct;24(5):801-14
pubmed: 15993517
Support Care Cancer. 2010 Apr;18(4):433-7
pubmed: 19562384
JPEN J Parenter Enteral Nutr. 2019 Nov 17;:
pubmed: 31736112
Nutrition. 2020 Sep 2;:111006
pubmed: 33051113
Nutr J. 2015 Dec 10;14:123
pubmed: 26652158
JPEN J Parenter Enteral Nutr. 2000 Nov-Dec;24(6):329-36
pubmed: 11071592
Head Neck. 1997 Aug;19(5):419-25
pubmed: 9243270
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Nutrition. 1999 Jun;15(6):458-64
pubmed: 10378201
Nutrients. 2020 Mar 20;12(3):
pubmed: 32245095
Support Care Cancer. 2006 Nov;14(11):1152-6
pubmed: 16622648
Clin Nutr. 2020 Nov;39(11):3504-3511
pubmed: 32273200
JPEN J Parenter Enteral Nutr. 2012 May;36(3):292-8
pubmed: 22045723
Clin Nutr. 2019 Jun;38(3):1274-1279
pubmed: 29853223
Br J Cancer. 2010 Mar 16;102(6):966-71
pubmed: 20160725
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Belinda Steer (B)

Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Jenelle Loeliger (J)

Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Lara Edbrooke (L)

Allied Health Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Physiotherapy Department, The University of Melbourne, Parkville, VIC 3052, Australia.

Irene Deftereos (I)

Department of Surgery, Western Health, The University of Melbourne, Melbourne, VIC 3000, Australia.
Department of Nutrition and Dietetics, Western Health, Footscray, VIC 3011, Australia.

Erin Laing (E)

Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Nicole Kiss (N)

Allied Health Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC 3220, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH